Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2014
08/19/2014US8809326 Isoquinolinone Rho kinase inhibitors
08/19/2014US8809261 Compositions containing delta-9-THC-amino acid esters and process of preparation
08/19/2014US8808984 Method for synthesising templated molecules
08/19/2014US8808961 Composition, resist film, pattern forming method, and inkjet recording method
08/19/2014CA2649924C Inhibitors of c-fms kinase
08/19/2014CA2625034C 3-alkyl-5-(4-alkyl-5-oxo-tetrahydrofutran-2-yl)pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors
08/14/2014WO2014124418A1 Modulators of methyl modifying enzymes, compositions and uses thereof
08/14/2014WO2014122067A1 New indanyloxydihydrobenzofuranylacetic acids
08/14/2014WO2014100719A3 Teatrahydro- and dihydro-isoquinoline prmt5 inhibitors and uses thereof
08/14/2014US20140228408 Novel rock kinase inhibitors
08/14/2014US20140228394 Inhibitors of cyp 17
08/14/2014US20140228387 Disubstituted 5-fluoro-pyrimidines
08/14/2014US20140228386 17a-HYDROXYLASE/C17,20-LYASE INHIBITORS
08/14/2014US20140228373 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
08/14/2014US20140228363 Tetrasubstituted cyclohexyl compounds as kinase inhibitors
08/14/2014US20140228360 Prmt5 inhibitors and uses thereof
08/14/2014US20140228358 Acyclic cyanoethylpyrazoles as janus kinase inhibitors
08/14/2014US20140228351 Substituted indazole derivatives active as kinase inhibitors
08/14/2014US20140228348 Cyanomethylpyrazole carboxamides as janus kinase inhibitors
08/14/2014US20140228343 Prmt5 inhibitors and uses thereof
08/14/2014US20140228340 Benzonitrile derivatives as kinase inhibitors
08/13/2014EP2763982A1 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
08/13/2014EP2763979A1 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
08/13/2014EP2763968A1 Herbicidal pyridazinone derivatives
08/13/2014CN103987706A 吡啶酮衍生物以及含有吡啶酮衍生物的药物 Pyridinone derivatives, and the drug-containing pyridone derivatives
08/13/2014CN103987701A N-(1,2,5-噁二唑-3-基)-、n-(1,3,4-噁二唑-2-基)-、n-(四唑-5-基)-和n-(三唑-5-基)-芳基甲酰胺及其作为除草剂的用途 N- (1,2,5- oxadiazol-3-yl) -, n- (1,3,4- oxadiazol-2-yl) -, n- (tetrazol-5-yl) - and n- (triazol-5-yl) - aryl carboxamide and their use as herbicides
08/13/2014CN103987698A 作为激酶lrrk2调节剂用于治疗帕金森病的2-苯基氨基嘧啶衍生物 Amino-pyrimidine derivatives as kinase lrrk2 modifier used to treat Parkinson's disease 2-phenyl
08/13/2014CN103987696A 作为因子xia抑制剂的取代的四氢异喹啉化合物 As the substituted tetrahydroisoquinoline compounds factor inhibitors xia
08/13/2014CN103980259A 黄酮类或异黄酮类化合物及其用途 Flavonoids or isoflavones and their use
08/13/2014CN103980258A 作为缓激肽b1拮抗剂的化合物 B1 compounds as bradykinin antagonists
08/13/2014CN103980257A 8-硝基-2-四氮唑基-4-羰基苯并吡喃的合成方法 8- nitro-tetrazolium benzo pyran-4-carbonyl synthetic method
08/13/2014CN103980254A 一种有机电致发光化合物 An organic electroluminescent compounds
08/13/2014CN103980252A 制备含1,2,4-三氮唑的吡唑类席夫碱治疗肿瘤的药物 Pyrazoles drug treatment of tumors Schiff bases containing 1,2,4-triazole preparation of
08/13/2014CN103980235A Gpr120受体激动剂及其用途 Gpr120 receptor agonists and their use
08/13/2014CN103980205A N-3-磺酰乙胺取代-5-环丙烷螺环乙内酰脲衍生物及其制备方法和应用 N-3- sulfonamide amine-substituted-5 cyclopropane spiro hydantoin derivatives, preparation method and application
08/13/2014CN103980202A 一种具有除草活性的4-苯甲酰吡唑类化合物 4-benzoyl-pyrazole compounds having herbicidal activity
08/13/2014CN102675401B 抗肿瘤药物lqc-y的制备及其应用 Preparation and Application of antineoplastic lqc-y
08/13/2014CN102503895B 苯并咪唑取代的丙烯腈衍生物的制备方法 Preparation of benzimidazole-substituted acrylonitrile derivative
08/13/2014CN102453025B 拉帕替尼中间体晶型及其制备方法 Lapatinib intermediate crystal and preparation method
08/13/2014CN102321034B 硫代苯二氮卓类化合物及其作为药物的用途 Thiosulfate benzodiazepine class of compounds and their use as medicaments
08/13/2014CN102186844B 放射性标记的甘氨酸1转运蛋白抑制剂 The radiolabeled glycine transporter 1 inhibitor
08/13/2014CN101605781B 芳基羧酸环己基酰胺衍生物 Aryl carboxylic acid cyclohexyl amide derivatives
08/12/2014US8802868 Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
08/12/2014US8802865 2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)
08/12/2014US8802703 Arylamino N-heteraryl compounds as MEK inhibitors
08/12/2014US8802675 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
08/12/2014US8802665 Pyrrolidine derivatives
08/12/2014US8802597 Herbicidal pyrimidines
08/12/2014CA2683941C Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
08/12/2014CA2585172C Sulfonyl-substituted bicyclic compounds as modulators of ppar
08/07/2014WO2014121040A1 Flap modulators
08/07/2014WO2014119892A1 Method for preparation of justicidin a derivatives of arylnaphthalene lignan structure
08/07/2014WO2014118197A1 Radiolabeled quinazoline derivatives
08/07/2014WO2014118133A1 Pyridine derivatives as soft rock inhibitors
08/07/2014WO2014117947A1 4-amino substituted condensed pyrimidine compounds as pde4 inhibitors
08/07/2014WO2014060493A3 N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group
08/07/2014WO2014060375A3 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
08/07/2014US20140221668 Process
08/07/2014US20140221644 New routes to trans a,b-substituted bacteriochlorins
08/07/2014US20140221431 Novel histone deacetylase inhibitor of benzamides and use thereof
08/07/2014US20140221430 Solid Forms of 3-(6-(1-(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)Cyclopropanecarboxamido)-3-Methylpyridin-2-yl)Benzoic Acid
08/07/2014US20140221428 Arylsulfonamide ccr3 antagonists
08/07/2014US20140221406 Quinazoline-7-ether compounds and methods of use
08/07/2014US20140221405 Platelet adp receptor inhibitors
08/07/2014US20140221403 Quinazoline based egfr inhibitors containing a zinc binding moiety
08/07/2014US20140221393 Itraconazole Analogs and Use Thereof
08/07/2014US20140221387 Compositions and methods useful for treating diseases
08/07/2014US20140221376 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
08/07/2014US20140221373 Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase
08/07/2014US20140221371 Heterocyclic compounds and their use as binding partners for 5-ht5 receptors
08/07/2014US20140221366 Substituted Azaheterocycles for the Treatment of Cancer
08/07/2014US20140221351 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
08/07/2014US20140221349 Indanyloxydihydrobenzofuranylacetic acids
08/07/2014US20140221348 Novel bicyclic antibiotics
08/07/2014US20140221347 Therapeutic compounds
08/07/2014US20140221346 Therapeutic compounds
08/07/2014US20140221345 Prmt5 inhibitors and uses thereof
08/07/2014US20140221342 6-substituted phenoxychroman carboxylic acid derivatives
08/07/2014US20140221339 Heterocyclic Derivative and Pharmaceutical Drug
08/07/2014US20140221336 Compounds useful as inhibitors of janus kinases
08/07/2014US20140221335 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
08/07/2014US20140221322 Heteroaryl substituted urea modulators of fatty acid amide hydrolase
08/07/2014US20140221317 Novel compounds as receptor modulators with therapeutic utility
08/07/2014US20140221310 Flap modulators
08/07/2014US20140219960 Novel composition for preventing or treating hepatitis c virus, regulating phosphorylation of replicase
08/06/2014EP2762478A1 Aromatic amine derivative and organic electroluminescence element using same
08/06/2014EP2762477A1 Material for organic electroluminescent element, and organic electroluminescent element produced using same
08/06/2014EP2762476A1 1,2,4-triazine-6-carboxamide derivative
08/06/2014EP2762475A1 Pharmaceutically acceptable salts of quinolinone compounds and their medical use
08/06/2014EP2760858A1 Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders
08/06/2014EP2760833A1 Pyridine derivatives
08/06/2014EP2760831A1 Viral replication inhibitors
08/06/2014EP2760830A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
08/06/2014EP2760829A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
08/06/2014EP2760828A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
08/06/2014CN103974950A 作为ccr(4)拮抗剂的取代的苯并咪唑类和苯并吡唑类 As ccr (4) antagonists substituted benzimidazoles and benzo pyrazoles
08/06/2014CN103974948A 在治疗过度增殖性疾病中用作bub1激酶抑制剂的取代的苄基吲唑 Substituted bub1 kinase inhibitors used in the treatment of hyperproliferative diseases benzyl indazole
08/06/2014CN103974945A 用于制备神经氨酸衍生物的方法 Preparation process for derivatives of neuraminic acid
08/06/2014CN103974944A 用作kv3抑制剂的乙内酰脲衍生物 The inhibitor used kv3 hydantoin derivative
08/06/2014CN103965198A 替卡格雷的中间体及其制备方法以及利用该中间体制备替卡格雷的方法 Ticagrelor intermediates and preparation methods and the use of a method for preparing the intermediate ticagrelor
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 694